Prognostic factors of second hematopoietic allogeneic stem cell transplantation among hematological malignancy patients relapsed after first hematopoietic stem cell transplantation: A single center study.

Yue Lu,Jian-Ping Zhang,Yan-Li Zhao,Min Xiong,Rui-Juan Sun,Xing-Yu Cao,Zhi-Jie Wei,Jia-Rui Zhou,De-Yan Liu,Jun-Fang Yang,Xian Zhang,Dao-Pei Lu,Peihua Lu

Frontiers in immunology（2022）

引用 2|浏览12

暂无评分

摘要

Allo-HSCT2 is feasible and patients with good prognostic features prior to allo-HSCT2 -disease status of CR/MRD- and HCT-CI score of 0 as well as a second donor with a new mismatched haplotype could have the maximal benefit from the second allo-HSCT.

查看译文

关键词

first allogeneic hematopoietic stem cell transplantation,hematological malignancy,prognosis factor,relapse,second allogeneic hematopoietic stem cell transplant

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要